| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/21/2015 | CN102670532B 伊潘立酮药物组合物及其制备方法 Iloperidone pharmaceutical compositions and methods for preparing |
| 01/21/2015 | CN102665768B 肽清除剂 Peptide scavengers |
| 01/21/2015 | CN102558524B 聚乙二醇-含环醚侧基的聚酯嵌段共聚物及其应用 Polyester block copolymers and application containing a cyclic ether side groups - polyethylene glycol |
| 01/21/2015 | CN102548544B 同时具有速效特性和长效特性的药物组合物 The pharmaceutical composition of both fast-acting and long-acting properties characteristic |
| 01/21/2015 | CN102525879B 制备阿瑞匹坦固体分散组合物的方法 Preparation of aprepitant solid dispersion method of compositions |
| 01/21/2015 | CN102414116B 用于制备尺寸可控的纳米颗粒的超分子方法 Supramolecular method for preparing nanoparticles controllable size |
| 01/21/2015 | CN102327257B 氯桂丁胺缓释药物组合物 Gui butylamine chlorine release pharmaceutical composition |
| 01/21/2015 | CN102227210B 亲脂性物质溶液,特别是药物溶液 Lipophilic substance solution, in particular a pharmaceutical solution |
| 01/21/2015 | CN102133196B 离子结合组合物 Ion binding composition |
| 01/21/2015 | CN102076362B 尼古丁锭剂组合物 Nicotine lozenge composition |
| 01/20/2015 | US8937180 Method for preparing a polymer conjugate |
| 01/20/2015 | US8937163 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/20/2015 | US8937161 Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates |
| 01/20/2015 | US8937157 Therapeutic nuclease compositions and methods |
| 01/20/2015 | US8937101 Thickening polymer for ionic oil phases free of monomers |
| 01/20/2015 | US8937098 Dermatological compositions comprising at least one naphthoic acid compound and at least one film-forming agent and treatment of keratinization disorders therewith |
| 01/20/2015 | US8937085 Pharmaceutical carrier composition and pharmaceutical composition |
| 01/20/2015 | US8937081 Statin bioavailability enhancement delivery composition |
| 01/20/2015 | US8937074 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
| 01/20/2015 | US8937048 Anti-angiogenic compounds |
| 01/20/2015 | US8937045 Liquid formulations of tumor necrosis factor-binding proteins |
| 01/20/2015 | US8936942 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 01/20/2015 | US8936907 Neural transfection reagents |
| 01/20/2015 | US8936815 Device for external use in alternative medicine applications |
| 01/20/2015 | US8936813 Spray drying methods and related compositions |
| 01/20/2015 | US8936812 Tamper-resistant oral opioid agonist formulations |
| 01/20/2015 | US8936809 Method for treating prostate diseases based on local delivery of active substances |
| 01/20/2015 | US8936803 Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof |
| 01/20/2015 | US8936800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
| 01/20/2015 | US8936797 Polymeric thickener composition |
| 01/20/2015 | US8936784 Absorbable in situ gel-forming system, method of making and use thereof |
| 01/20/2015 | CA2649199C Method of increasing the in vivo recovery of therapeutic polypeptides |
| 01/20/2015 | CA2618240C Sustained-release formulations of topiramate |
| 01/20/2015 | CA2572915C Pharmaceutical composition containing botulinum neurotoxin |
| 01/20/2015 | CA2546452C Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 01/20/2015 | CA2377204C Purification and stabilization of peptide and protein pharmaceutical agents |
| 01/17/2015 | CA2821348A1 Functionalized nanodiamonds as delivery platforms for nucleic acids |
| 01/15/2015 | WO2015006764A1 Compositions and methods for improving rebaudioside m solubility |
| 01/15/2015 | WO2015006763A1 Rebaudioside x to provide sweetness enhancement |
| 01/15/2015 | WO2015006758A1 Functionalized polymer particles for biosensing |
| 01/15/2015 | WO2015006740A2 Oligonucleotide-ligand conjugates and process for their preparation |
| 01/15/2015 | WO2015006429A1 Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery |
| 01/15/2015 | WO2015006319A1 Treatment of papulopustular rosacea with ivermectin |
| 01/15/2015 | WO2015006305A1 Treatment of inflammatory lesions of rosacea with ivermectin |
| 01/15/2015 | WO2015006271A1 Fluorescent polymers and applications thereof |
| 01/15/2015 | WO2015005748A1 Bioactive polypeptide monomer-immunoglobulin fc fragment conjugate having decreased receptor-mediated clearance, and method for preparing same |
| 01/15/2015 | WO2015005723A1 Cell-penetrating peptide and conjugate comprising same |
| 01/15/2015 | WO2015005459A1 Pharmaceutical composition for respiratory administration |
| 01/15/2015 | WO2015005458A1 Glycosaminoglycan derivative and method for producing same |
| 01/15/2015 | WO2015005443A1 Oral composition |
| 01/15/2015 | WO2015005419A1 External-use composition producing foamed state upon use |
| 01/15/2015 | WO2015005409A1 Aqueous ophthalmic composition containing cyclosporine a |
| 01/15/2015 | WO2015005345A1 Core-shell crosslinked hyaluronic acid gel particles, production method for same, and medical material |
| 01/15/2015 | WO2015005253A1 Novel lipid |
| 01/15/2015 | WO2015005241A1 Ultrafast-disintegrating tablet and method for manufacturing same |
| 01/15/2015 | WO2015005219A1 Dispersion liquid and method for forming hydrogel |
| 01/15/2015 | WO2015005060A1 Method for producing ellagic acid composition |
| 01/15/2015 | WO2015004450A1 Liposomal drug delivery system for bone cements |
| 01/15/2015 | WO2015004400A1 Novel antibody-drug conjugates and the use of same in therapy |
| 01/15/2015 | WO2015004243A1 Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation |
| 01/15/2015 | WO2015003747A1 Composition containing modified derivatives of a cytidine antimetabolite for the treatment of susceptible disease |
| 01/15/2015 | WO2015003479A2 Orally administered solid pellet for infants and children and preparation method therefor |
| 01/15/2015 | WO2015003478A2 Orally disintegrating pill for infants and children and preparation method therefor |
| 01/15/2015 | WO2014170681A9 Oligosaccharide conjugates and methods of use |
| 01/15/2015 | US20150018755 Substance delivery device and substance delivery method using the same |
| 01/15/2015 | US20150018752 Delivery system and process |
| 01/15/2015 | US20150018748 Chitosan-derived compositions |
| 01/15/2015 | US20150018747 Methods and compositions to treat myocardial conditions |
| 01/15/2015 | US20150018531 Anti sez6 antibodies and methods of use |
| 01/15/2015 | US20150018530 Novel Prodrug Containing Molecule Compositions and Their Uses |
| 01/15/2015 | US20150018526 Cytotoxins comprising modified bouganin toxin for the treatment of cancer |
| 01/15/2015 | US20150018516 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer |
| 01/15/2015 | US20150018486 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 01/15/2015 | US20150018435 Polyunsaturated fatty acid-containing oil product and uses and production thereof |
| 01/15/2015 | US20150018434 Composition for oral delivery of veterinary drugs and supplements to animals |
| 01/15/2015 | US20150018433 Fluorinated polymerizable hydrogels for wound dressings and methods of making same |
| 01/15/2015 | US20150018432 Compositions and Methods Using Rebaudioside X to Provide Sweetness Enhancement |
| 01/15/2015 | US20150018428 Lutein/zeaxanthin for glare protection |
| 01/15/2015 | US20150018423 Injectable Osteogenic Formula and Method of Using Same |
| 01/15/2015 | US20150018421 Treatment of Sleep Disturbances |
| 01/15/2015 | US20150018416 Aqueous Ophthalmic Composition |
| 01/15/2015 | US20150018327 Neuroactive steroid formulations and methods of treating cns disorders |
| 01/15/2015 | US20150018324 Testosterone undecanoate compositions |
| 01/15/2015 | US20150018320 Hormone Containing Emulsion Comprising Krill Phospholipids |
| 01/15/2015 | US20150018319 Treatment of skin disease |
| 01/15/2015 | US20150018308 Preparation of Triple Responsive Nanogel System and its Application |
| 01/15/2015 | US20150018295 Method for the preparation of triglycerides of medium-chain length fatty acids |
| 01/15/2015 | US20150018284 Formulations and methods of use for alpha connexin c-terminal (act) peptides |
| 01/15/2015 | US20150018279 Compositions and methods for delivery of kinase inhibiting peptides |
| 01/15/2015 | US20150017699 Internally functionalized graphene substrates |
| 01/15/2015 | US20150017249 Sustained-release formulations of topiramate |
| 01/15/2015 | US20150017246 Novel crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof |
| 01/15/2015 | US20150017245 Methods of treating cancers with therapeutic nanoparticles |
| 01/15/2015 | US20150017240 Pharmaceutical compositions comprising a ph-dependent component and ph-raising agent |
| 01/15/2015 | US20150017237 Dosage form comprising lopinavir and ritonavir |
| 01/15/2015 | US20150017234 Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages |
| 01/15/2015 | US20150017233 Arginine-based lipids for delivery of therapeutics |
| 01/15/2015 | US20150017229 Method and system for synthesizing nanocarrier based long acting drug delivery system for insulin |
| 01/15/2015 | US20150017224 Method for producing a tissue paper sheet material containing an adjuvant substance for the treatment of allergic rhinitis, and the product obtained |
| 01/15/2015 | US20150017216 Compositions and methods for target delivering a bioactive agent to aquatic organisms |